Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsKelly J Atkins, Tiffany R Brailow, Alexandra J Weigand, et al.
The Journal of Clinical Investigation|March 6, 2002
Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosisNitin J Karandikar, Michael P Crawford, Xiao Yan, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer's disease assessmentDarren M Weber, Steven W Taylor, Robert J Lagier, et al.
Frontiers in Neurology|April 10, 2024
Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer's disease assessmentDarren M Weber, Steven W Taylor, Robert J Lagier, et al.
Archives of Neurology|October 15, 2008
Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumabMaria del Pilar Martin, Petra D Cravens, Ryan Winger, et al.
Multiple Sclerosis and Related Disorders|January 5, 2025
Self-reported longitudinal COVID-19 vaccination reactogenicity profiles in persons with multiple sclerosisFarren B S Briggs, Hollie Schmidt, Farrah J Mateen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 10, 2021
COVID-19 Vaccination Reactogenicity in Persons With Multiple SclerosisFarren Basil Shaw Briggs, Farrah J Mateen, Hollie Schmidt, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 21, 2022
Multiple Sclerosis Followed by Neuromyelitis Optica Spectrum Disorder: From the National Multiple Sclerosis Society Case Conference ProceedingsCarolyn Goldschmidt, Steven L Galetta, Robert P Lisak, et al.
Multiple Sclerosis and Related Disorders|July 20, 2021
Brain volume change after high-dose immunosuppression and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosisHyunwoo Lee, Kunio Nakamura, Sridar Narayanan, et al.
Archives of Neurology|October 13, 2006
Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosisOlaf Stüve, Christina M Marra, Amit Bar-Or, et al.
Pageof 12